Tenon Medical, Inc. — Form 8-K
Filed August 10, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
Tenon Medical (market cap ~$7.3M) executed a 1-for-35 reverse stock split, effective August 10, 2026, converting each 35 outstanding shares into 1 share. The split was approved by stockholders on July 23, 2026. The stated purpose is to raise per-share price above the $1.00 minimum required for continued Nasdaq Capital Market listing. No fractional shares will be issued; all fractional interests are rounded up to whole shares.
Why this rating
Reverse split signals delisting risk and shareholder dilution concerns; material for tiny-cap company but does not change operations or finances directly. Necessary defensive move.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.